PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis

Journal of Autoimmunity

Volumn 43, Issue , 2013, Pages 1-9

  Larman, H Benjamin ^a,b,c,d   Laserson, Uri ^a,e,f   Querol, Luis ^f,g   Verhaeghen, Katrijn ^d   Solimini, Nicole L ^c,d   Xu, George Jing ^a,c,d   Klarenbeek, Paul L ^h   Church, George M ^f   Hafler, David A ^f,g   Plenge, Robert M ^d,h   Nigrovic, Peter A ^h,i   De Jager, Philip L ^j   Weets, Ilse ^d,k   Martens, Geert A ^d   O'Connor, Kevin C ^l   Elledge, Stephen J ^c,d  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^h BOSTON CHILDREN S HOSPITAL   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j Belgian Diabetes Registry   (Belgium)

^k UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^l HARVARD UNIVERSITY   (United States)

more..

Author keywords

Autoantigen discovery; High throughput screening; PhIP Seq; Proteomics

Indexed keywords

AUTOANTIBODY; PEPTIDE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID; CHILD; DATA BASE; DNA FINGERPRINTING; FEMALE; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOPRECIPITATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PHAGE DISPLAY; PHAGE IMMUNOPRECIPITATION SEQUENCING; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SYNOVIAL FLUID;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; PEPTIDE LIBRARY; YOUNG ADULT;

EID: 84878348595     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2013.01.013     Document Type: Article

References (23)

1. Larman H.B., Zhao Z., Laserson U., Li M.Z., Ciccia A., Gakidis M.A., et al. Autoantigen discovery with a synthetic human peptidome. Nat Biotechnol 2011, 29:535-541.
2. HB Larman, M Salajegheh, R Nazareno, T Lam, J Sauld, H Steen, et al. Cytosolic 5'-nucleotidase 1a autoimmunity in sporadic inclusion body myositis, annals of neurology, in press.
3. Fernando M.M., Stevens C.R., Walsh E.C., De Jager P.L., Goyette P., Plenge R.M., et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 2008, 4:e1000024.
4. Zhang L., Eisenbarth G.S. Prediction and prevention of type 1 diabetes mellitus. J Diabetes 2011, 3:48-57.
5. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004, 14:164-174.
6. Link H., Huang Y.M. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol 2006, 180:17-28.
7. Edwards J.C., Szczepanski L., Szechinski J., Filipowicz-Sosnowska A., Emery P., Close D.R., et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004, 350:2572-2581.
8. Saag K.G., Teng G.G., Patkar N.M., Anuntiyo J., Finney C., Curtis J.R., et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008, 59:762-784.
9. Pescovitz M.D., Greenbaum C.J., Krause-Steinrauf H., Becker D.J., Gitelman S.E., Goland R., et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 2009, 361:2143-2152.
10. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008, 358:676-688.
11. De Grijse J., Asanghanwa M., Nouthe B., Albrecher N., Goubert P., Vermeulen I., et al. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials. Diabetologia 2010, 53:517-524.
12. Vermeulen I., Weets I., Asanghanwa M., Ruige J., Van Gaal L., Mathieu C., et al. Contribution of antibodies against IA-2beta and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age. Diabetes Care 2011, 34:1760-1765.
13. Wenzlau J.M., Liu Y., Yu L., Moua O., Fowler K.T., Rangasamy S., et al. A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 2008, 57:2693-2697.
14. O'connor K.C., Mclaughlin K.A., De Jager P.L., Chitnis T., Bettelli E., Xu C., et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med 2007, 13:211-217.
15. Meyer M., Kircher M. Illumina sequencing library preparation for highly multiplexed target capture and sequencing. Cold Spring Harbor Protoc 2010, 2010. [pdb prot5448].
16. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001, 98:5116-5121.
17. Efron B., Tibshirani R. An introduction to the bootstrap 1993, Chapman & Hall, New York.
18. Bailey T.L., Elkan C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol 1994, 2:28-36.
19. Cepok S., Zhou D., Srivastava R., Nessler S., Stei S., Bussow K., et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 2005, 115:1352-1360.
20. Elphick G.F., Querbes W., Jordan J.A., Gee G.V., Eash S., Manley K., et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004, 306:1380-1383.
21. Cortese I., Tafi R., Grimaldi L.M., Martino G., Nicosia A., Cortese R. Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. Proc Natl Acad Sci U S A 1996, 93:11063-11067.
22. Rand K.H., Houck H., Denslow N.D., Heilman K.M. Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis. J Neurol Neurosurg Psychiatr 1998, 65:48-55.
23. Srivastava R., Aslam M., Kalluri S.R., Schirmer L., Buck D., Tackenberg B., et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med 2012, 367:115-123.